ArticleVeterinary research communications2025
The promising activity of apple cider vinegar on MDR Klebsiella spp. (K. variicola and K. pneumoniae) emerging pathogens in chicken.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Klebsiella spp. is identified as a zoonotic pathogen with a growing concern for poultry. To address this pathogen, 125 chicken samples were collected. Klebsiella variicola (K. variicola) was first detected in Egypt. The findings revealed an isolation of (30.4%) of Klebsiella spp (K. pneumoniae (94.7%) and Klebsiella variicola (K.variicola) (5.3%). The capsular typing of K. pneumoniae isolates revealed that 15.8%, 36.8%, 10.5%, 26.3%, and 5.3% belonged to phylogenetic groups K1, K2, K5, K54, and K57, respectively. The Klebsiella isolates exhibited remarkable resistance against ampicillin (94.7%), cefotaxime (89.5%), and ceftazidime (86.9%). Notably, 91.6% of the isolates were susceptible to imipenem, making it a drug of choice. 50% of Klebsiella isolates were XDR, while 47.4% were MDR with MAR indices ≥ 0.5, indicating they originated from high-risk contamination sources. 97.4% of isolates harbored at least one β-lactams resistance gene, of which bla
Indexed as
Identifiers
41385133What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.